Last updated: February 28, 2022
Sponsor: Vanderbilt University
Overall Status: Terminated
Phase
2/3
Condition
Dizzy/fainting Spells
Circulation Disorders
Low Blood Pressure (Hypotension)
Treatment
N/AClinical Study ID
NCT00581477
030750
P01HL056693
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- patients with severe orthostatic hypotension and other autonomic symptoms who do notmeet criteria for one of our standard diagnoses
- non-smokers
- drug-free
- able to give informed consent
- free of pulmonary, renal, hematopoietic, hepatic and cardiac disease
Exclusion
Exclusion Criteria:
- medications affecting the autonomic nervous system
- any chronic illness (cardiac, pulmonary, endocrine, gastrointestinal, rheumatologic)
- anemia (Hct < 30)
- women of childbearing age who are pregnant or nursing
- smokers
Study Design
Total Participants: 8
Study Start date:
January 01, 2004
Estimated Completion Date:
December 31, 2020
Study Description
Connect with a study center
Vanderbilt University
Nashville, Tennessee 37232
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.